Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating the combination of bupropion and varenicline for smoking cessation in male smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: Duke University | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2015-10-08